Over the past 12 months, information about the SARS-CoV-2 virus (or COVID-19 as it is commonly known) continues to emerge. A wealth of information appears on the website of the U.S. Centers for Disease Control and Prevention (2021) about the virus, management, vaccines, quarantine, and new variants. A search of the National Library of Medicine’s (NLM) National Center for Biotechnology Information’s database (PubMed) identified over 90,000 COVID-19 related articles already in print from around the world (NLM, 2021). Approximately 800 clinical trials examining a variety of biologics for COVID-19 intervention are also underway (all phases) worldwide (NLM ClinicalTrials.gov, 2021).
The role of audiology in the management of COVID-19 patients has emerged as survivors begin to experience a continuance of their health issues post-discharge or a late onset of medical problems. This group of patients has been referred to as COVID-19 “long-haulers.” COVID-19 survivors may also experience auditory/vestibular problems. DiSogra (2020) addresses this issue in detail and offers suggestions for ongoing monitoring.
This article will address whether COVID-19 can be found in cerumen and what precautions need to be taken with current patients and ‘long-haulers.’
Recent Posts
Termination of Federal EHDI Grants
Earlier this week, the Academy learned that seven federal cooperative agreements funded by the U.S. Health Resources and Services Administration (HRSA) are being terminated. Despite…
Discover What’s New (and Worth the Trip) at AAA 2026
We’re gearing up for an unforgettable convention, and we’re excited to share what’s new in San Antonio! This year’s convention brings fresh programming, expanded learning…
Congress Introduces Legislation to Protect Audiology Students’ Access to Federal Loans
New bipartisan legislation (H.R. 6718) introduced in the U.S. House of Representatives would restore audiology to the federal definition of a professional degree under the…


